Cannamedical® Pharma GmbH Conducts First Closing on 12MEUR Strategic Investment Round Led by Healthcare Executive Steve Wiggins
Cologne, Germany (ots) - Cannamedical® Pharma GmbH, the leading independent brand in Germany's fast-growing medical cannabis market, announced today the first closing of a new 12MEUR strategic investment round and the addition of Steve Wiggins to the Company's Board of Directors. Mr. Wiggins is one of the most ...
more